Related Experiment Video
Updated: Oct 10, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.6K
Simulation study using the spots deletion technique in spot scanning proton beam therapy for prostate cancers
Nobuyoshi Fukumitsu1, Tomokatsu Hayakawa2, Tomohiro Yamashita3
1Department of Radiation Oncology, Kobe Proton Center, Kobe, Hyogo 650-0047, Japan.
Molecular and Clinical Oncology
|December 15, 2021
Summary
Deleting distant spots in proton beam therapy (PBT) plans can reduce radiation dose to organs at risk (OAR). This spot deletion technique modified plans for prostate cancer patients, improving safety without affecting treatment time.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment
Background:
- Spot scanning proton beam therapy (PBT) is an advanced radiation technique.
- Optimizing dose distribution and beam delivery time is crucial for PBT efficacy and safety.
- The spot deletion technique offers a potential method for plan optimization.
Purpose of the Study:
- To investigate the impact of spot deletion on dose distribution and beam delivery time in PBT.
- To evaluate two distinct spot deletion strategies: by weighting deposition and by distance from the clinical target volume (CTV).
- To assess the dosimetric changes in organs at risk (OAR) and the target volume (exCTV) for prostate cancer patients.
Main Methods:
- A spot scanning plan was created for 30 prostate cancer patients.
- Two modification processes were applied: Process A (deleting low-weighting spots) and Process B (deleting spots distant from CTV).
- Dose distributions, including V50 Gy(RBE) for rectum/bladder, V60 Gy(RBE) for urethral bulb, and exCTV inhomogeneity index (INH), were compared between initial and modified plans.
Main Results:
- Process B significantly improved dose distribution, reducing V50 Gy(RBE) to the rectum and bladder and V60 Gy(RBE) to the urethral bulb.
- Process B resulted in a slight increase in the exCTV inhomogeneity index.
- Process A did not significantly alter OAR doses, exCTV parameters, or beam delivery time.
Conclusions:
- Systemic deletion of spots distant from the CTV (Process B) in spot scanning PBT can effectively reduce radiation dose to OAR.
- This optimization strategy holds promise for enhancing treatment safety in PBT without compromising treatment delivery.
- Further investigation into the clinical implications of these dosimetric improvements is warranted.

